Related Experiment Videos
CEA serum levels in non-neoplastic disease
1Nuclear Medicine Service, Hospital Central de Asturias, Oviedo, Spain.
The International Journal of Biological Markers
|July 1, 1992
Summary
Elevated Carcinoembryonic Antigen (CEA) levels can occur in non-neoplastic conditions like inflammation or organ insufficiency. Various factors, including tissue, physiological, metabolic, circulating, and methodological influences, affect CEA values in these cases.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Oncology Biomarkers
Background:
- Plasma Carcinoembryonic Antigen (CEA) levels can be elevated in non-neoplastic conditions such as inflammation, benign tumors, and renal or hepatic insufficiency.
- Typically, CEA elevations in these non-malignant pathologies remain below 10 ng/ml.
Purpose of the Study:
- To comprehensively review the factors influencing Carcinoembryonic Antigen (CEA) levels in non-malignant diseases.
- To highlight the importance of considering these factors for accurate interpretation of CEA test results in clinical practice.
Main Methods:
- Literature review and synthesis of existing data on Carcinoembryonic Antigen (CEA) influencing factors.
- Classification of influencing factors into five main categories: tissular, physiological, metabolic, circulating, and methodological.
Main Results:
- Tissular factors (synthesis, expression, release), metabolic factors (liver, biliary, renal function), circulating factors (CEA-like substances, autoantibodies, immunocomplexes), and methodological factors (assay characteristics) all impact CEA levels.
- These diverse factors contribute to variations in CEA concentrations observed in non-malignant conditions.
Conclusions:
- Accurate interpretation of Carcinoembryonic Antigen (CEA) test results requires careful consideration of numerous factors beyond malignancy.
- Understanding these influences is crucial for optimizing the clinical utility of CEA as a biomarker.